{
  "company": "CIPLA",
  "report_date": "November 4, 2022",
  "filename": "CIPLA_transcript_Nov_2022.pdf",
  "quarter": "Q2",
  "fiscal_year": "2023",
  "management_team": [
    "MR. UMANG VOHRA - MANAGING DIRECTOR &",
    "MR. ASHISH ADUKIA - GLOBAL CHIEF FINANCIAL",
    "MR. NAVEEN BANSAL - HEAD, INVESTOR RELATIONS,",
    "UMANG VOHRA - MANAGING DIRECTOR &",
    "ASHISH ADUKIA - GLOBAL CHIEF FINANCIAL",
    "NAVEEN BANSAL - HEAD, INVESTOR RELATIONS,"
  ],
  "moderator": "Ladies and gentlemen, good day and welcome to the Q2 FY'23 Earnings Conference Call of \nCipla Limited",
  "analysts": [
    {
      "name": "Tushar \nManudhane",
      "firm": "Motilal Oswal Financial Services"
    },
    {
      "name": "Prakash Agarwal",
      "firm": "Axis Capital"
    },
    {
      "name": "Kunal Dhamesha",
      "firm": "Macquarie"
    },
    {
      "name": "Neha Manpuria",
      "firm": "Bank of America"
    },
    {
      "name": "Surya Patra",
      "firm": "PhillipCapital"
    },
    {
      "name": "Damayanti Kerai",
      "firm": "HSBC"
    },
    {
      "name": "Nithya Balasubramaniam",
      "firm": "Bernstein"
    },
    {
      "name": "Vivek",
      "firm": "Citi"
    },
    {
      "name": "Ritesh Rathod",
      "firm": "Nippon India"
    },
    {
      "name": "Nitin Agarwal",
      "firm": "DAM Capital"
    }
  ],
  "qa_segments": [],
  "key_financial_metrics": {
    "revenue_inr_crores": "5829",
    "growth_percentage": "6",
    "increase_percentage": "7.2",
    "ebitda_margin_percentage": "22.3",
    "ebitda_inr_crores": "1302"
  },
  "business_highlights": [
    "launched eight new brands in Cardiology, Diabetes, Urology, \nGynecology and Respiratory.",
    "launched the product."
  ],
  "extraction_metadata": {
    "extraction_date": "2025-08-03T01:08:55.242185",
    "source_file": "data\\cipla\\CIPLA_transcript_Nov_2022.pdf",
    "text_length": 50529,
    "extraction_method": "PyMuPDF + Regex parsing + Filename analysis"
  }
}